|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01558 HEC CJ PHARM
Nominal 
9.020 +0.200 (+2.268%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,673,212 | 1,699,909 | (662,510) | 1,299,493 |
| Net Cash from / (used in) Investing Activities | -- | 554,568 | (1,120,161) | (439,106) | (2,094,628) |
| Net Cash from / (used in) Financing Activities | -- | (1,476,899) | (787,027) | 187,479 | 64,633 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 750,881 | (207,279) | (914,137) | (730,502) |
| Cash & Cash Equivalents at beginning of period | -- | 923,543 | 1,131,121 | 2,044,967 | 2,779,138 |
| Effect of Foreign Exchange Rate Changes | -- | (11) | (299) | 291 | (3,669) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,674,413 | 923,543 | 1,131,121 | 2,044,967 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 684,731 |
| %Change | -33.489% |
| EPS / (LPS) | RMB 0.780 |
| NBV Per Share (¥) | RMB 9.847 |